Healthcare >> CEO Interviews >> July 29, 2016
R. Michael Kleine is President and Chief Executive Officer of Miramar Labs, Inc. Mr. Kleine has been with Miramar Labs since February 2014. Mr. Kleine is an established leader with a proven track record of success in leading several global biomedical companies. With nearly two decades of experience in C-suite positions, he has experience commercializing new technologies, increasing revenues and growing organizations. Previous positions held include President and CEO roles with EndoGastric Solutions; Sorin Biomedical; Biosensors International Group Ltd., a publicly traded company; Thermo Cardiosystems, which was acquired by Thoratec; and MicroVention, a startup, which was acquired by Terumo. Profile
TWST: Would you provide a brief overview of the company and its core technology? How does that technology differ from the current standard of care?
Mr. Kleine: The